Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization.
Cancer Med. 2021 Aug;10(15):5256-5269. doi: 10.1002/cam4.4081. Epub 2021 Jun 21.
Cancer Med. 2021.
PMID: 34152094
Free PMC article.
Nanoscale Zeolitic Imidazolate Framework (ZIF)-8 in Cancer Theranostics: Current Challenges and Prospects.
Xie H, Liu X, Huang Z, Xu L, Bai R, He F, Wang M, Han L, Bao Z, Wu Y, Xie C, Gong Y.
Xie H, et al.
Cancers (Basel). 2022 Aug 15;14(16):3935. doi: 10.3390/cancers14163935.
Cancers (Basel). 2022.
PMID: 36010926
Free PMC article.
Review.
Item in Clipboard
Frontline anti-PD-1/PD-L1 versus bevacizumab in advanced non-small-cell lung cancer: a network meta-analysis.
Chen J, Liu X, Zhang J, Huang Z, Zeng W, Hu J, Chen G, Gong Y, Liu Y, Xie C.
Chen J, et al.
Future Oncol. 2022 Apr;18(13):1651-1664. doi: 10.2217/fon-2021-0838. Epub 2022 Feb 7.
Future Oncol. 2022.
PMID: 35129371
Review.
Item in Clipboard
Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion.
Zhang J, Li Y, Dai W, Tang F, Wang L, Wang Z, Li S, Ji Q, Zhang J, Liao Z, Yu J, Xu Y, Gong J, Hu J, Li J, Guo X, He F, Han L, Gong Y, Ouyang W, Wang Z, Xie C.
Zhang J, et al.
Cancer Immunol Immunother. 2024 Mar 2;73(4):71. doi: 10.1007/s00262-024-03657-x.
Cancer Immunol Immunother. 2024.
PMID: 38430394
Free PMC article.
Item in Clipboard
RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma.
Jiang X, Li Y, Zhang N, Gao Y, Han L, Li S, Li J, Liu X, Gong Y, Xie C.
Jiang X, et al.
Cell Biosci. 2021 Apr 15;11(1):74. doi: 10.1186/s13578-021-00586-5.
Cell Biosci. 2021.
PMID: 33858512
Free PMC article.
Item in Clipboard
PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer.
Zhang N, Gao Y, Zeng Z, Luo Y, Jiang X, Zhang J, Li J, Zhang J, Gong Y, Xie C.
Zhang N, et al.
Clin Transl Oncol. 2021 Sep;23(9):1827-1837. doi: 10.1007/s12094-021-02591-z. Epub 2021 Mar 28.
Clin Transl Oncol. 2021.
PMID: 33774805
Item in Clipboard
Cite
Cite